Literature DB >> 25516144

Monitoring intrahepatic cholestasis of pregnancy using the fetal myocardial performance index: a cohort study.

A Henry1,2,3,4, A W Welsh1,2,4.   

Abstract

OBJECTIVE: To investigate use of the fetal myocardial performance index (MPI) in assessing intrahepatic cholestasis of pregnancy (ICP).
METHODS: This was a cohort study including cross-sectional and longitudinal data from 31 women with ICP recruited from June 2012 to March 2014. Fetal left, right and delta MPI (LMPI, RMPI and DMPI), and routine measures of fetal growth and wellbeing, were obtained at each ultrasound examination. Results were evaluated with respect to gestational age (GA)-adjusted reference intervals, level of maternal serum bile acid (SBA) and fetal outcome. Lower SBA (≥ 7.5 and < 40 μmol/L) and high SBA (≥ 40 μmol/L) subgroups of cases were defined for the analysis.
RESULTS: A total of 51 ultrasound examinations were performed in 33 fetuses. The mean LMPI, and means of its isovolumetric relaxation time (IRT) and isovolumetric contraction time (ICT) components were significantly higher in all subgroups of cases of ICP relative to the normal reference mean. Considering only the first examination in each case of ICP, IRT was significantly more prolonged in the high SBA group (n = 10) in comparison to the lower SBA group (n = 23) (52.7 ± 8.0 ms vs 47.3 ± 4.8 ms, P = 0.02), and both IRT (r = 0.538, P = 0.001) and LMPI (r = 0.367, P = 0.036) were significantly correlated with SBA concentration. The proportion of high SBA cases with LMPI, RMPI or DMPI > 2 SD above the GA-adjusted reference mean was not significantly greater than for the lower SBA group. On analysis of all data from those cases with more than one examination, no significant correlation was found between SBA concentration and any of the MPI variables.
CONCLUSIONS: LMPI values increase above the population GA-adjusted mean in cases of ICP, particularly amongst women with higher SBA. A significant correlation between IRT and LMPI at initial examination and increasing SBA concentration was found. A future multicenter prospective study may clarify the prognostic utility of MPI in ICP.
Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Tei index; functional fetal echocardiography; intrahepatic cholestasis of pregnancy; myocardial performance index

Mesh:

Year:  2015        PMID: 25516144     DOI: 10.1002/uog.14769

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  4 in total

1.  Efficacy of fetal left ventricular modified myocardial performance index in predicting adverse perinatal outcomes in intrahepatic cholestasis of pregnancy.

Authors:  Koray Gök; Taha Takmaz; Osman Köse; Bilge Kapudere; Nevin Tüten; Mehmet Sühha Bostancı; Selçuk Özden
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-07       Impact factor: 1.712

2.  Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.

Authors:  Tharni Vasavan; Sahil Deepak; Indu Asanka Jayawardane; Maristella Lucchini; Catherine Martin; Victoria Geenes; Joel Yang; Anita Lövgren-Sandblom; Paul Townsend Seed; Jenny Chambers; Sophia Stone; Lesia Kurlak; Peter Hendy Dixon; Hanns-Ulrich Marschall; Julia Gorelik; Lucy Chappell; Pam Loughna; Jim Thornton; Fiona Broughton Pipkin; Barrie Hayes-Gill; William Paul Fifer; Catherine Williamson
Journal:  J Hepatol       Date:  2020-12-01       Impact factor: 25.083

3.  [Intrahepatic cholestasis of pregnancy].

Authors:  Carsten Hagenbeck; Ulrich Pecks; Frank Lammert; Matthi As C Hütten; Felix Borgmeier; Tanja Fehm; Ekkehard Schleußner; Holger Maul; Sven Kehl; Amr Hamza; Verena Keitel
Journal:  Gynakologe       Date:  2021-04-20

4.  Reference ranges of fetal heart function using a Modified Myocardial Performance Index: a prospective multicentre, cross-sectional study.

Authors:  Lijuan Sun; Jingjing Wang; Xiaoting Su; Xinlin Chen; Yuqing Zhou; Xiaoming Zhang; Hong Lu; Jianmei Niu; Lan Yu; Congxin Sun; Wenjun Zhang; Jijing Han; Lina Zhang; Zhenna Wang; Peiwen Chen; Tiantian Chen; Hua Hong; Lulu Zhou; Baoying Ye; Wei Guo; Wei Zhao; Na Zhang; Zhen Li; Sheng Zhao; Qingqing Wu; Jiawei Tian; Yuxin Jiang
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.